Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb827766e457fe43360c5865a8f2e56b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 |
filingDate |
2010-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b52522a95c7693b98da406e4a94b44e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cdd78ca164353dff35d1d70046feebc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c77d2bb8ca745013eb0360b8bc9dd29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f997f70bfb2e6471b48ba6facdfc6b7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f62f883a3704bd9592d3620fe9006b56 |
publicationDate |
2010-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010240625-A1 |
titleOfInvention |
Ophthalmic Formulations of Cetirizine and Methods of Use |
abstract |
The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9533053-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9815865-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9822142-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10912765-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8765725-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113712908-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3653205-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3634415-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8791154-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018226942-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10174071-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10954263-B2 |
priorityDate |
2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |